Location History:
- Los Angeles, CA (US) (2010)
- Irvine, CA (US) (2016)
Company Filing History:
Years Active: 2010-2016
Title: Innovations of Inventor Hongna Han
Introduction
Hongna Han is a notable inventor based in Irvine, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. With a total of 2 patents, his work has the potential to impact the treatment of various diseases.
Latest Patents
One of his latest patents is titled "Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling." This invention provides isoquinoline, quinoline, and quinazoline derivatives that can be used to treat a variety of disorders, diseases, and pathologic conditions. Specifically, it focuses on the use of these derivatives to inhibit the hedgehog signaling pathway, which is crucial in the treatment of hyperproliferative diseases and pathologic angiogenesis. Another significant patent is "Analogs of ansamycin and pharmaceutical compositions thereof." This patent involves analogs of geldanamycin, a type of ansamycin, and includes pharmaceutical formulations comprising such analogs, along with methods of use for treating tumors.
Career Highlights
Throughout his career, Hongna Han has worked with prominent companies in the biotechnology sector. Notable among these are Nantbioscience, Inc. and Abraxis Bioscience, LLC. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Hongna has collaborated with several professionals in his field, including Chunlin Tao and Xiaowen Sun. These collaborations have likely enhanced his research and development efforts, leading to the successful patents he holds today.
Conclusion
In summary, Hongna Han is a distinguished inventor whose work in pharmaceuticals has led to valuable innovations. His patents reflect a commitment to addressing critical health issues through scientific advancements.